Indication for intervention and the most appropriate treatment of mitral regurgitation

Czech version

Authors: H. Línková
Authors‘ workplace: III. interní-kardiologická klinika LF UK a FN Královské Vinohrady, Praha
Published in: Kardiol Rev Int Med 2015, 17(4): 325-330
Category: Cardiology Review

Overview

This overview study summarises the current view on mitral regurgitation from a clinical perspective. The aim of the manuscript is to describe the different types of mitral regurgitation focusing on their etiology and current therapeutic approaches and to point out the different indication criteria for surgical procedures or percutaneous interventions in individual types of mitral regurgitation.

Keywords:
primary mitral regurgitation – secondary mitral regurgitation – surgical treatment – percutaneous interventions

Sources

1. Nkomo VT, Gardin JM, Skelton TN et al. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368: 1005– 1011. doi:10.1016/ S0140-6736(06)69208-8.

2. Lung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231– 1243. doi.10.1016/ S0195-668X(03)00201-X.

3. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet 2009; 373: 1382– 1394. doi: 10.1016/ S0140-6736(09)60692-9.

4. Mehta RH, Eagle KA, Coombs LP et al. Influence of age on outcomes in patients undergoing mitral valve replacement. Ann Thorac Surg 2002; 74: 1459– 1467.

5. Mirabel M, Iung B, Baron G et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007; 28: 1358– 1365. doi: 10.1093/ eurheartj/ ehm001.

6. Iung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231– 1243. doi: 10.1016/ S0195-668X(03)00201-X.

7. Čerbák R. Chronicke regurgitačni chlopenni vady leveho srdce včera a dnes. Interv Akut Kardiol 2002; 2: 85– 89.

8. Enriquez-Sarano M. Timing of mitral valve surgery. Heart 2002; 87: 79– 85. doi: 10.1136/ heart.87.1.79.

9. Trichon BH, Felker GM, Shaw LK et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003; 91: 538– 543. doi: 10.1016/ S0002-9149(02)03301-5.

10. Lancellotti P, Moura L, Peirard LA et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2:mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010; 11: 307– 332. doi: 10.1093/ ejechocard/ jeq031.

11. Endrys J. Invazivni hemodynamicke metody. Hradec Kralove: Nucleus 2005: 102– 108.

12. Vahanian A, Alfieri O, Andreotti F et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2012; 42: S1– S44. doi: 10.1093/ ejcts/ ezs455.

13. Nishimura RA, Otto CM, Bonow RO et al. 2014 AHA/ ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2014; 148: e1– e132. doi: 10.1016/ j.jtcvs.2014.05.014.

14.Tribouilloy CM, Enriquez-Sarano M, Schaff H et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation 1999; 99: 400– 405. doi: 10.1161/ 01.CIR.99.3.400.

15. Marcotte F, Honos GN, Walling AD et al. Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function. Can J Cardiol 1997; 13: 479– 485.

16. Enriquez-SaranoM, Tajik AJ, Schaff HV et al. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 1994; 90: 830– 837. doi: 10.1161/ 01.cir.90.2.830.

17. Detaint D, Sundt TM, Nkomo VT et al. Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements. Circulation 2006; 114: 265– 272. doi: 10.1161/ cirulationaha.106.619239.

18. David TE, Armstrong S, Sun Z et al. Late results of mitral valve repair for mitral regurgitation due to degenerative disease. Ann Thorac Surg 1993; 56: 7– 12.

19. Fedak PW, McCarthy PM, Bonow RO. Evolving concepts and technologies in mitral valve repair. Circulation 2008; 117: 963– 974. doi: 10.1161/ circulationaha.107.702035.

20. David TE. Outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Semin Thorac Cardiovasc Surg 2007; 19: 116– 120. doi: 10.1053/ j.semtcvs.2007.04.004.

21. Otto CM. Valvular heart disease. Philadelphia: WB Saunders 1999: 296– 322.

22. Russo A, Suri RM, Grigioni F et al. Clinical outcome after surgical correction of mitral regurgitation due to papillary muscle rupture. Circulation 2008; 118: 1528– 1534. doi: 10.1161/ circulationaha.107.747949.

23. Glower DD, Tuttle RH, Shaw LK et al. Patient survival charakteristic after routine mitral valve repair for ischemic mitral regurgitation. J Thorac Cardiovas Surg 2005; 129: 860– 868. doi: 10.1016/ j.jtcvs.2004.11.023.

24. Lancellotti P, Pierard LA. Chronic ischaemic mitral regurgitation: exercise testing reveals its dynamic component. Eur Heart J 2005; 26: 1816– 1817. doi: 10.1093/ eurheartj/ ehi418.

25. Kang DH, Kim MJ, Kang SJ et al. Mitral valve repair versus revascularization alone in the treatment of ischemic mitral regurgitation. Circulation 2006; 114 (Suppl 1): 499– 503. doi: 10.1161/ circulationaha.105.000398.

26. Lam BK, Gillinov AM, Blackstone EH et al. Importance of moderate ischemic mitral regurgitation. Ann Thorac Surg 2005; 79: 462– 470. doi: 10.1016/ j.athoracsur.2004.07.040.

27. St. John Sutton MG, Plappert T, Abraham WT et al. Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003; 107: 1985– 1990.

28. Magne J, Senechal M, Dumesnil JG et al. Ischemic mitral regurgitation: a complex multifaceted disease. Cardiology 2009; 112: 244– 259. doi: 10.1159/ 000151693.

29. Rankin JS, Daneshmand MA, Milano CA et al. Mitral repair for ischemic mitral regurgation: review of current techniques. Heart Lung Vessel 2013; 5: 246– 251.

30. Deja MA, Grayburn PA, Sun B et al. Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation 2012; 125: 2639– 2648. doi: 10.1161/ circulationaha.111.072256.

31. Smith PK, Puskas JD, Ascheim DD et al. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 2014; 371: 2178– 2188. doi: 10.1056/ NEJMoa1410490.

32. Lancellotti P, Troisfontaines P, Toussaint AC et al. Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction. Circulation 2003; 108: 1713– 1717. doi: 10.1161/ 01.CIR.0000087599.49332.05.

33. Harris KM, Sundt TM 3rd, Aeppli D et al. Can late survival of patients with moderate ischemic mitral regurgitation be impacted by intervention on the valve? Ann Thorac Surg 2002; 74: 1468– 1475.

34. Tamburino C, Ussia GP, Maisano F et al. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J 2010; 31: 1382– 1389. doi: 10.1093/ eurheartj/ ehq051.

35. Herrmann HC, Kar S, Siegel R et al. Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. EuroIntervention 2009; 4: 437– 442.

36. Feldman T, Kar S, Rinaldi M et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) Cohort. J Am Coll Cardiol 2009; 54: 686– 694. doi: 10.1016/ j.jacc.2009.03.077.

37. Zamorano JL, Gonzales-Gomez A, Lancellotti P. Mitral valve anatomy: implications for transcatheter mitral valve interventions. EuroIntervention 2014; 10 (Suppl U): U106– U111. doi: 10.4244/ EIJV10SUA15.